HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrike Graab Selected Research

GANT 61

4/2015Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrike Graab Research Topics

Disease

3Neoplasms (Cancer)
04/2015 - 01/2012
1Leukemia
10/2016
1Rhabdomyosarcoma
10/2016
1Neoplasm Metastasis (Metastasis)
06/2012
1Glioblastoma (Glioblastoma Multiforme)
01/2012
1Neuroblastoma
01/2012
1Sarcoma (Soft Tissue Sarcoma)
01/2012

Drug/Important Bio-Agent (IBA)

2PI103IBA
04/2015 - 01/2012
1Arsenic Trioxide (Trisenox)FDA Link
10/2016
1GANT 61IBA
04/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2012
1DNA (Deoxyribonucleic Acid)IBA
06/2012
1Transcription Factors (Transcription Factor)IBA
06/2012
1Caspase 3 (Caspase-3)IBA
01/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2012
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
01/2012
1AnthracyclinesIBA
01/2012

Therapy/Procedure

1Transplantation
06/2012